KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker

.

Source: Critical Reviews in Clinical Laboratory Sciences - February 12, 2024 Category: Laboratory Medicine Authors: Nina-Naomi KreisHa Hyung MoonLinda WordemanFrank LouwenChristine SolbachJuping YuanAndreas Rittera Obstetrics and Prenatal Medicine, Gynaecology and Obstetrics, University Hospital Frankfurt, J. W. Goethe-University, Frankfurt, Germanyb Department of Phys Source Type: research